HPV-positive cervical or oropharyngeal cancers contain wild type p53 and/or RB, and inactivation of these tumor suppressors are driven by E6 and E7 proteins produced from high-risk HPVs[28-30]. This evidence concerns the gene TP53 and neoplasm.